These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 627181)

  • 21. [Clinical characteristics and typological classification of endogenous depression resistant to treatment].
    Bondar' VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(1):84-8. PubMed ID: 1319660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative approaches to refractory depression in bipolar illness.
    Post RM; Leverich GS; Denicoff KD; Frye MA; Kimbrell TA; Dunn R
    Depress Anxiety; 1997; 5(4):175-89. PubMed ID: 9338110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Some current aspects of antidepressive therapy].
    Predescu V; Vianu I
    Neurol Psihiatr Neurochir; 1967; 12(6):485-94. PubMed ID: 5593224
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapy possibilities for therapy-resistant depressions.
    Berner P; Kryspin-Exner K; Poeldinger W
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Jul; 7(4):189-93. PubMed ID: 4614274
    [No Abstract]   [Full Text] [Related]  

  • 25. Intravenous chlorimipramine and depressive subtypes.
    Escobar JI; Teeter RR; Tuason VB; Schiele BC
    Dis Nerv Syst; 1976 Jun; 37(6):325-8. PubMed ID: 1277983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scopolamine sleep treatment in private practise.
    Goldner RD
    Int J Neuropsychiatry; 1967 Jun; 3(3):234-47. PubMed ID: 6039771
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of bipolar depression: an update.
    Fountoulakis KN; Grunze H; Panagiotidis P; Kaprinis G
    J Affect Disord; 2008 Jul; 109(1-2):21-34. PubMed ID: 18037498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A closer look at treatment resistant depression: is it due to a bipolar diathesis?
    Sharma V; Khan M; Smith A
    J Affect Disord; 2005 Feb; 84(2-3):251-7. PubMed ID: 15708423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Trial of G 34-586 perfusions in 43 patients].
    Margat P; Broussot T
    Ann Med Psychol (Paris); 1969 Mar; 1(3):461-8. PubMed ID: 5376739
    [No Abstract]   [Full Text] [Related]  

  • 31. Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression.
    de Jonghe F; Swinkels J; Tuynman-Qua H
    Pharmacopsychiatry; 1991 Jan; 24(1):21-7. PubMed ID: 1901418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Objective therapy predictors in depression: a multivariate approach.
    Weckowicz TE; Yonge KA; Cropley AJ; Muir W
    J Clin Psychol; 1971 Jan; 27(1):4-29. PubMed ID: 5539326
    [No Abstract]   [Full Text] [Related]  

  • 33. [The place of psychopharmacology in the treatment of depressions (author's transl)].
    Titeca J
    Acta Psychiatr Belg; 1978; 78(5):746-55. PubMed ID: 751467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical experience with maprotilin and maprotilin/clomipramine infusions in resistant depression.
    Zapletálek M; Zbytovský J; Kudrnová K
    Act Nerv Super (Praha); 1982 May; 24(2):73-6. PubMed ID: 7102227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial.
    Berk M; Copolov DL; Dean O; Lu K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Bush AI
    Biol Psychiatry; 2008 Sep; 64(6):468-75. PubMed ID: 18534556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A control study of intravenous versus oral clomipramine in major depression].
    Zhao J
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Feb; 25(1):9-12, 60. PubMed ID: 1591963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Considerations on the therapeutic management of mixed psychoses and of depressive manifestations symptomatic of schizophrenia].
    Scala A
    Osp Psichiatr; 1967; 35(4):501-34. PubMed ID: 5607254
    [No Abstract]   [Full Text] [Related]  

  • 38. [Depressive forms of schizophrenia. Trial of clomipramine treatment].
    Postel M; Czermack M; Postel J
    Encephale; 1971; 60(4):312-34. PubMed ID: 5151300
    [No Abstract]   [Full Text] [Related]  

  • 39. [On some problems of lithiotherapy (author's transl)].
    Náhunek K; Svestka J
    Cesk Psychiatr; 1977 Oct; 73(5):297-302. PubMed ID: 610895
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical and biochemical contributions on the effect of maprotiline and clomipramine in depressive states (preliminary observation)].
    Ravizza L
    Psychiatr Clin (Basel); 1979; 12(3):164-72. PubMed ID: 94169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.